The WACC of SynAct Pharma AB (SYNACT.ST) is 6.2%.
| Range | Selected | |
| Cost of equity | 5.00% - 7.30% | 6.15% |
| Tax rate | 8.80% - 10.50% | 9.65% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.0% - 7.3% | 6.2% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.5 | 0.62 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.00% | 7.30% |
| Tax rate | 8.80% | 10.50% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.0% | 7.3% |
| Selected WACC | 6.2% | |